The use of surfagon for the induction of ovulation of mares in ART cycles

In order to predict the timing of ovulation in mares, to obtain mature oocytes and follicular fluid in ART cycles, the domestic analogue of GnRH surfagon was used in two doses (40 and 50 mcg) against the background of comparison with the effectiveness of the previously used hCG drug. Surfagon injections were carried out intramuscularly when the leading follicle reached a diameter of 35 mm or more, and there was maximum or decreased edema of the uterus. An analysis of the duration of the intervals between intramuscular injection of 40 µg and 50 µg of the drug and ovulation showed that 72.4 and 35% of ovulations occur, respectively, between 37 and 48 hours after injection. The result of using 40 µg of surfagon is similar to the results of using hCG - 72 and 74% of ovulations in this period, respectively. Therefore, the drug “Surfagon” at a dose of 40 µg is most suitable for use in ART cycles. Only 3.4% of ovulations after the use of 40 µg of surfagon occur in the interval up to 24 hours after injection. Therefore, its use allows planning the collection of follicular fluid and oocyte from the preovulatory follicle using the OPU method after 24 hours. The domestic drug Surfagon (lyuleberin acetate, CJSC Mosagrogen, Moscow) is effective for the induction of ovulation in mares and can serve as an alternative to the use of HCG and imported GnRH analogues both in normal reproduction practice and in planning OPU procedures for the purpose of follicular fluid intake and oocyte extraction.

1. Bøgh, I.B., Bézard, J., Duchamp, G., Baltsen, M., Gérard, N., Daels, P., Greve.T. (2002). Pure preovulatory follicular fluid promotes in vitro maturation of in vivo aspirated equine oocytes. J. Theriogenology, 57 (7), 1765-1779. doi: 10.1016/s0093-691x(02)00650-7.

2. Dell'Aquila, M.E., ChoY.S., Minoia.P., Traina.V., G.M.Lacalandra. G.M., Maritato.F. (1997). Effects of follicular fluid supplementation of in-vitro maturation medium on the fertilization and development of equine oocytes after in-vitro fertilization or intracytoplasmic sperm injection. J. Human Reproduction, 12(12), 2766–2772.

3. Satué, K., Gardón, J.C. (2013). A Review of the Estrous Cycle and the Neuroendocrine Mechanisms in the Mare. J. Steroids Horm. Sci, 4(2), 2

4. Ginther, O.J., Utt, M.D., Bergfelt, D.R., & Beg, M.A. (2006). Controlling Interrelationships of progesterone/LH and estradiol/LH in mares. Anim. Reprod. Sci. 95.144–150.

5. Solodova E.V. Factors influencing the effectiveness of embryo transplantation. / E.V. Solodova // Horse breeding and equestrian sport. – 2018, No. 3, pp. 30-31.

6. Sauberli, D.S. (2013). The effectiveness and efficiency of ovulation induction agents in mares (Academic dissertation) Urbana, Illinois: Veterinary Clinical Medicine in the Graduate College of the University of Illinois at Urbana-Champaign., 1-31

7. Solodova E.V. Efficiency of repeated use of human chorionic gonadotropin in mares / E.V. Solodova // Horse breeding and equestrian sport. – 2019, No. 3, pp. 36-37.

8. Ferreira-Silva, J.C., Nascimento, P.S., Moura, M.T., Basto, S.R.L., Azevedo, M.V., Rocha, J.M., Filho, José, P.S. & Lemos, O.M.A. (2018). Induction of Ovulation in Mangalarga Marchador Mares by hCG or GnRH. J. Acta Scientiae Veterinariae, 46, 1536.

9. Green, J.M., Raz, T., Epp, T., Carley, S.D., & Card, C.E. (2007). Relationships between utero-ovarian parameters and ovulatory response to human chorionic gonadotrophin (hCG) in mares. In: AAEP Annual Convention-Orlando, 2007 by American Association of Equine Practitioners 563–567. Retrieved from https://www.ivis.org/library/aaep/aaep-annual-convention-orlando

10. Lebedeva L.F., Atroshchenko M.M. The use of human chorionic gonadotropin to stimulate ovulation of follicles in mares. / Lebedeva L.F., Atroshchenko M.M. // Veterinary medicine. -2017. - No. 5. – P. 35-38.

11. Loy, R. G., & Hughes, J. P. (1966). The effect of HCG on ovulation, length of estrus and fertility in the mare. J. Cornell Vet., 56(1), 41-50

12. Phetudomsinsuk, K. (2017). Investigation into the effect of prostaglandin F2a, GnRH analogue and hCG on induction of ovulation in mares. Thai. Vet. Med., 47(4), 493-499

13. Irvine, C., & Alexander, S. (1994). The dynamics of gonadotropin-releasing hormone, LH and FSH secretion during the spontaneous ovulatory surge of the mare as revealed by intensive sampling of pituitary venous blood. J.Endocrinology, 140(2), 283-295.

14. Kaiser, U.B., Conn, P.M., & Chinet, W.W. (1997). Studies of gonadotropin–releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. J. Endocrine Reviews, 18(1), 46-70.

15. Ingwerson, J.A. (2007). Induction of ovulation and LH response in cyclic mares treated with gonadorelin diacetate tetrahydrate. Retrospective Theses and Dissertations. Retrieved from https://lib.dr.iastate.edu/rtd/14897

16. Pinto, C.R.F. (2013) Hormones and Breeding. In-depth: reproductive endocrinology, AAEP proceeding, 59, 331-336. Retrieved from https://aaep.org/sites/default/files/issues/Repro Pinto1.pdf

17. Ganheim, A., & Jochle, W. (1995). Acceleration and timing of fertile ovulation in cyclic mares with a deslorelin implant. J. Acta Veterinaria Scandinavica, 36(4), 393-400.

18. Barrier-Battut, I., & Le Poutre, N. (2001). Use of buserelin to induce ovulation in the cyclic mare. J. Theriogenology, 55, 1679-1695.

19. Ferris, R. A., Lindholm, A. R. G., Scofield, D. B., & Hatzel, J. N. (2012). Efficacy of deslorelin acetate (Sucromate) on induction of ovulation in American Quarter Horse mares. J. Equine Veterinary Science, 32(5), 286-288.

20. Lindholm, A., Scofield, D. B., McCue P. M., & Ferris, D. (2011). Comparison of deslorelin and histrelin for induction of ovulation in mares. J. Equine Veterinary Science, 31(5), 312-313.

21. Solodova E.V. Analysis of the pregnancy rate of mares in natural and stimulated cycles of various durations. / E.V. Solodova //Horse breeding and equestrian sport. – 2019. - No. 1. – P. 20-23.